Tag: Opioids
Transition to Long-Term Opioid Use High in Patients With Rheumatic Disease
Of those initiating opioids for the first time, patients with fibromyalgia made up the highest proportion of long-term opioid users
Racial, Ethnic Differences ID’d in Receipt of Meds to Treat Opioid Use Disorder
More White than Black and Hispanic patients receive buprenorphine, naloxone, benzodiazepines in 180 days after index event
Vibrating Crib Mattress Beneficial for Newborns With Prenatal Opioid Exposure
Newborns with prenatal opioid exposure assigned to vibrating mattress had fewer days of treatment, received less morphine
Eat, Sleep, Console Approach Beneficial for Neonatal Opioid Withdrawal
Eat, Sleep, Console care approach reduces the number of days until medical readiness for hospital discharge
Report IDs Those Likely to Receive Meds for Opioid Use Disorder in Pregnancy
Persons receiving medication for opioid use disorder more likely to be older, White and to have public insurance
2016 to 2021 Saw Increase in Drug Overdose Rates Involving Fentanyl
Increase seen in age-adjusted drug overdose death rates involving methamphetamine, cocaine; decrease reported in death rates involving oxycodone
Opioid Exposure Higher Among Adults With Cerebral Palsy Versus Those Without
Exposures occur for a higher number of days per month and for a longer duration after the initial exposure
2016 to 2022 Saw Initiation Rate of Buprenorphine Increase, Stabilize
Median monthly retention rate was 22.2 percent during January 2016 through April 2022
Maker of Narcan Nasal Spray Plans to Sell Overdose Antidote for Less Than $50
The U.S. Food and Drug Administration approved OTC Narcan nasal spray last month to be sold without a prescription
Fibromyalgia Is Risk Factor for Opioid Use Disorder Exacerbations
New instrument, the Pain-related OUD Exacerbation Scale, shows validity
